MCL1 and B-cell chronic lymphocytic leukemia: The major determinants of resistance to venetoclax in MCL and CLL patients have been identified as the overexpression and de novo synthesis of BCL-XL and MCL-1, antiapoptotic proteins belonging to the BCL2 family (20).